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Abstract
The folate receptor is overexpressed on the surface of numerous cancer cell types including
those of the breast, lung, kidney, ovary, and brain [1, 2]. Recent interest has exploded in the use
of folate to deliver payloads and imaging agents to folate receptor positive cancer cells based on
several positive clinical trials including phase III trials of EC-145, which is poised to become the
first folate targeted, FDA approved drug [3]. Given the success of EC-145 and numerous other
agents in the pharmaceutical pipeline, there remains a great interest in the exploitation of this
technology in the delivery of nanoscale agents to folate receptor positive cancer cells [3]. In this
review I will examine the current status and role of folate targeted nanoconjugates for both
diagnostic imaging and therapy.
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Introduction
Cancer affects the lives of many people in more ways than one and is a leading cause of
death in today’s society. Radiation of the patient undergoing treatment for cancer with the use of
certain chemotherapies usually results in the destruction of healthy tissue that leaves the patient
with unwanted and harmful side effects. In the past two decades scientific research has come up
with many innovative procedures in detecting cancer and treating different types of cancer
without the unwanted side effects. One major breakthrough in cancer research has been the
discovery of the tumor associated antigen known as the folate receptor (FR) which has a high
binding affinity for the vitamin folic acid. Researchers have discovered ways of conjugating
nanoparticles such as BSANPs (bovine serum albumin nanoparticles), mesoporous silica, gold,
metallic and quantum dots to folic acid in an effort to selectively target cancerous cells that result
in cellular penetration causing apoptosis of the cell tissue that is specifically infected without the
harmful side effects that follow conventional treatments. Many nanoparticle conjugates that
have been used for selective targeting of cancers show promising results with the large payloads
of the drug entering the cell into the cytoplasm via attachment the nanoparticle and FA causing
its damage to the cell thus preventing the tumor cells from metastasizing. The greatest benefits of
using folate conjugated nanoparticles for cell targeting is the reduction in side effects as well as
the increase in the potency of the drug due to the large payload being taken into the cell through
endocytosis. The focus of this paper is mainly on the advancements of folate nanoparticle
conjugates that have been researched and used for bio-imaging in order to determine where
exactly the cancer is located and intracellular delivery of the drug causing the destruction of
6

cancerous cells by targeting the folate receptor which is normally found in large concentrations
on cancerous tissue.

Background
Folic acid or pteryol-L-glutamate belongs to the vitamin B family and is a necessary
compound or molecule used in many reactions by the body for red blood cell proliferation and is
involved in many reactions for DNA synthesis and repair (See Figure 1.) for chemical strucutre.
In the past decade or so researchers have indicated that there is an increased expression of the
folate receptor which has been identified as a tumor marker on many cancerous tissues such as
human lung, intestinal tract, kidney, ovary, breast, brain, colon, and endometrium [1, 4]. The
folate receptor is a glycopolypepetide with a high binding affinity KD<10-9 M for folic acid.
Human folate receptor falls into a family of genes that is categorized by three types –α, β, and –γ
each with its own specific tissue distribution and different binding affinities for folic acid [2, 5].
Folate receptor alpha is the most widely researched and over expressed form of the three and due
to the increased expression of FRα in epithelial tumor cells it has been considered as a good
targeting marker for the use with new selective anti-cancer drugs [6, 7]. The FRα is also
expressed on normal epithelial tissue one major concern is the destruction of healthy tissue
throughout the body and surrounding areas where the tumors are located but since the FRα has a
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restrictive anatomic distribution on the luminal surfaces of healthy epithelial tissue this spares
these tissues from FR targeted agents [6]. When designing folate nano-conjugates environmental
pH should be considered. Once folic acid forms a complex with the folate receptor the complex
is endocytosed with a change in pH environments, acidic environments that can modify the
nano-conjugate properties resulting in destruction, or formation of different complex and early
release of the payload as a result of the nano-conjugates coming together. Utilizing
nanoparticles conjugated to folate for targeting of the folate receptor should tolerate a wide pH
range in order to efficiently target the folate receptor and allow for a more controlled release of
the payload once endocytosed.
When using folate as a carrier a major concern is the rapid expulsion or release of the
nanoparticles through the reticuloendothelial system which is also over expressed with FRα.
Pegylation which is the attachment of nanoparticles to folic acid by polymeric chains allows for
longer systematic circulation thus larger concentrations of nanoparticles are able to reach their
target allowing for a higher uptake of drugs or other agents into the cells [8]. The compound
folic acid is a water soluble compound and has its advantages when used as a targeting agent for
tumor cells it has a low molecular weight of 441 Da, it has high affinity for the folate receptor
and inexpensive, stable, and non-immunogenic compared with proteins such as monoclonal
antibodies [9]. Nanoparticles have been of considerable interest in targeting cancerous cells
because of the reduced toxicities as well as the enhanced therapeutic effects. Nanoparticles show
sufficient physical and biological stability that facilitates entrapment of a large payload and drug
release they have good tolerability of components, as well as a simple conjugation process with
folic acid [9]. The development and use of nanoparticles conjugated to folic acid has tremendous
advantages in fighting cancer. Metallic nanoparticles are used in bio-imaging due to their
8

controllable light emission which allows for detection and location of the tumor cells,
photodynamic therapy allowing for the destruction of tumor cells in specific regions sparing the
surrounding healthy cells [8].
Pegylated nanoparticles for the enehancement of circulation and targeting of FR+ cancer
cells.
One problem with using conventional anticancer agents is not only do they target the
cancerous cells but they also target healthy cells and are easily excreted through the body and
systematic circulation. First the toxic effects of the drugs cause unnecessary cell death and
second rapid excretion of the drug and the nanoparticle by the body will reduce its targeting
efficiency [10, 11, 12]. One major goal is to increase systematic circulation of the drug in order
to deliver a large payload as well as increase the binding efficacy of the nanoconjugate without
damaging healthy tissue. Prior research has determined that the concentrations of the FR are
100-300 times higher on cancerous cells compared to healthy cells it has also been concluded
that as the stage of the cancer increases so does the FR density this benefits the use of
nanoparticles conjugated to folic acid allowing for a higher efficiency of binding to the FR and
delivery of a large payload or drug to the tumor cells [10, 11]. Targeting of tumors occurs
through the EPR method the enhanced permeability and retention effect which is based on the
fact that as tumor cells become larger they stimulate the production of new vessels that result in
leaky fenestrations that allow passage of macromolecules and NPs into the tumor cells [10, 14]
One major drawback of the FR is that high concentrations naturally occur in the proximal tubules
of the kidney which allows for excretion of folic acid as well the clearance of the nanoparticles
and necessary drugs needed to target the tumor cells. The development of PEG poly(ethyelene
glycol) backbones has been shown to reduce the clearance of nanoparticles by the
9

reticuloendothelial system in order to increase the targeting efficiency to the FR by increasing
the half-life of the nano-particles carrying the drug or payload in the blood stream [10, 11, 12].
The use of PEG spacers tethered to liposomes and folic acid for targeting of FR+ cells were
found to enter the target cells at much higher concentrations then the control groups with a cell
death count 85 times greater than the controls [1]. PEG backbones containing varying numbers
of –NH2 groups (Au-PAM4-20K-FA) PEG-tetra-amine molecular weight 20000, (PAM2-2k),
(PAM2-10k), PEG-diamine with molecular weights 2000 and 10000 respectively and (PSH22K) PEG-dithiol with moleculare weight 2000 were used to determine the targeting efficacy of
folate decorated nanoparticles to the FR+ cells [12]. (See Figure 2) In this study Battacharya et
el. determined that AuNPs had a much higher binding capacity to the sulfhydral groups on the
PEG-dithiol with PEG-tetra-amine having the second highest binding capacity to AuNPs. It was
also determined that PAM4-20K-AuNPs had a much higher binding efficiency to Folate then
Au-PSH2-2K [12]. Due to its higher binding efficiency to folate Au-PAM4-20K was used for
testing on OV-167 and OPM-1 ovarian cancer cells which show the highest concentration of
folate receptor compared to other cell lines such as OVCAR-5, and RPMI cells. After a 1 hr
treatment of Au-PAM4-20K to OV-167 TEM images show a more intense color compared to
OVCAR-5 which have lower FR expression. The images clearly indicate that nanoparticle
internalization is greater in cells lines that have higher concentrations of FR due to the attraction
of folate to the FR and the pegylation of the nanoconjugate. The uptake of Au-PAM4-20k was
also higher and showed a more intense color in OPM-1 cells compared to cells with lower FR
concentration (See Figure 3) [12]. Altering the attachment of folate to gold nanoconjugates by
using different PEG structures Battacharya et el. showed that amine containing PEG structures
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are the choice when tethering folic acid to nano-conjugates and that there is an increase in the
uptake of gold nanoparticles by FR+ cells..
Experiments to see which nano-conjugate had a higher cellular internalization were
implemented using mPEG–thioacetamide (mPEG-2000T):AuNPs, and FA-mPEG-thioacetamide
(mPEG-1500T):AuNPs which were then analyzed by transmission electron microscopy that
indicate the folate coated polyethylene glycol nanoparticles had a higher internalization and
selective uptake by KB cells then the mPEG- thioacetamide gold nanoparticles alone (See figure
4) [11]. The use of PEG backbones is an excellent way of increasing the circulation of
nanoparticles in vitro and in vivo resulting in a higher targeting efficiency as well as the delivery
of large payloads to FR+ cells.

Figure 2. Chemical structure of different PEG backbones [12]
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Figure 3. TEM images of OPM-1 cell treated for 1 hr with AuPAM4-20k-FA.
A, Internalization of AuPAM4-20k-FA cells. B, C, Images of A at higher magnification. The
micrographs with arrows show the internalization of gold nanoconjugates and their localization
in early and late endosomes. D, Rpresentative picture of the intracellular nanoconjugate uptake
by OPM-1 cells during a five minute treatment [12].
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Figure 4. Representation of the PEG-Modified AuNP used and their exposure to FR+ and FRcells [11].

Folate Nanoparticle Conjugates for intratcellular tracking of payloads and in Imaging of
Cancer cells
Nanoparticles conjugated with folic acid are not only beneficial in delivering large payloads
of medicine to the FR+ cells for destruction. Nanoparticles are very useful in MRI magnetic
resonance imaging for detecting where the cancerous tissue is, as well as a tracking device
allowing for real time visualization in where the medicine is being distributed. Folate
nanoparticle conjugates can be tethered to certain fluorescent probes in order to track the bio
distribution of the payloads through bio imaging. One of the first bio-imaging agents to be
conjugated with folic acid for imaging of cancer cells is ¹¹¹In. The light emitting agent was
preferred because of its short half-life and rapid excretion. Imaging agents that remain in Frcells will tend to contribute to nonspecific background and the therapeutic agents will usually
13

result in off target toxicity [1]. The use of ¹¹¹In-DTPA-FA clearly shows a more intense
luminescence throughout the patient that is malignant indicating that ¹¹¹In-DTPA-FA has been
endocytosed by the cancerous cells resulting in visualization of the cancer for site specific
targeting [1, 3].
Mesoporous Silica Nanoparticles
There are a number of Multifunctional nanoparticles which can be used to simultaneously
deliver large payloads of medicine as well as give real time visualization in the delivery of the
nano-conjugates. Mesoporous silica nanoparticles are an excellent source for conjugation to
folic acid in which fluorophores such as FITC can be thethered to and used in the imaging of
cancer. Silica already exists in the human body as silicone dioxide (28). Silica conjugated by a
PEG spacer to folic acid and tethered to FITC flourosceine isothiocyanate, NPs(FITC)-PEGFolate are used to deliver as well as track the payload by fluorescence. In order to prove that
PEG- Folate was conjugated to The Nps(FITC) FT-IR spectral analysis was done on NPs(FITC)PEG-Folate and NPs(FITC). As you can see from (figure 5) in the FT-IR spectra there are two
distinct peaks at 1500 cm-1 and 1657 cm-1 and corresponds to the benzene of the folate and the
NH2 of the nanoparticle resulting in the successful formation of the nano-conjugate [13].
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Figure 5. FT-IR spectra of NPs(FTIC)-PEG-Folate and NPs(FITC) [13].

(Figure 5.1) shows a diagram for the synthesis of NPs(FITC)-PEG-Folate. Observation of KB
cells under an inverted confocal microscope clearly indicates that NPs(FITC)-PEG-Folate have
higher internalization compared to NPs(FITC) and is indicated by the intense fluorescence for
KB cells that are FR+ and little or no fluorescence by those cells that are FR-. (See figure 5.2)
The use of the NPs (FITC) folate nano-conjugates with FR+ KB cells in this study researchers
were able to show the direct targeting and tracking of the nano-conjugates by fluorescence. [13].
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Figure 5.1
Preperation of NPs(FITC)-PEG-Folate. The maleimde end of the maleimide-FITC reacts with
thiol groups of 3-mercaptopropyltrimethoxysilane forming thioester linkages. Folate is then
activated using ethy(diethylaminopropyl) carbodiimide/N-hydroxysuccinimide and reacted with
NH2-PEG-maleimide to form the reactive intermediate maleimide-PEG-Folate which then reacts
with NPs(FITC) to produce NPs(FITC)-PEG-Folate [13].
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Figure 5.2 FR+ KB cells incubated in Non targeted NPs(FITC) nanoparticles top panel in
comparison with targeted NPs(FITC)-PEG-Folate at 37 degrees Celsius for 6 hours [13].

Magnetic Nanoparticles
Supraparamagnetic iron oxide nanoparticles such as magnetite Fe3O4 are also
multifunctional nanoparticles very useful in magnetic resonance imaging due their magnetic
properties. What makes Magnetic nanoparticles so useful for MRI is that they can be controlled
by their shape, size, and composition of their magnetic core [14]. Magnetic nanoparticles that
are not modified are very stable at low and high pH. Even though (supraparmagnetic iron oxide
nanoparticles) or SPIONs are very stable at different pH values iron oxide agglomeration can
occur in vivo resulting in inefficient nanoparticle distribution. To protect the uniformity and
stability of the SPIONs as well as provide a multitude of arms for conjugation to medicines and
their targeting receptors they can be coated with different polymers such as PEG, dextran, or
phospholipids in situ. SPIONs that are coated with PEG are very useful for cell targeting in that
17

they are able to bypass the reticuloendothelial system resulting in higher concentrations of NPs
to their target. Supraparamagnetic iron oxide nanoparticles can be conjugated with linker agents
that contain a sulfhydral group that binds the amino group that is on the SPION allowing for
control over the bound ligands. Hogman et el used SPIONs and linked them with transferrin
protein by using pyridyl disulfide (PD) and was able to show that there was a 4 fold increase in
the binding of Tf molecules for each individual SPION as well as a 10 fold improvement in
cellular uptake allowing for a more sensitive SPION for imaging [14]
In another study magnetic nanoparticles are conjugated to folic acid and coupled with
methacrylamido to formulate MA-FA-Fe3O4 nano-conjugates which were used to determine the
cellular internalization of the nanoparticles as well as to target the cancer cell in order to cause
cell death by apoptosis [15]. This study first revealed that a 4.5µg/ml concentration of the folic
acid conjugate is all that is required to cause cell apoptosis in 5RP7 cancer cells which have high
concentrations of the FR compared to NIH/3T3 cells. TEM images of the magnetic
nanoparticles can be seen in (figures 6) the TEM images of MA-FA-Fe3O4 indicate that first
cellular internalization of the nano-conjugate has occurred and second the nanoparticles are
imaged [15]. The TEM images in (Figure 6.1) of normal cells incubated with MA-FA-Fe3O4
shows that internalization of the nano-conjugate has occurred and indicates high cell viability
after 24 and 48 hour treatment of the MA-FA-Fe3O4 with no internal damage due to the cells
remaining intact [15]. Comparing the TEM images of the 5RP7 cells incubated with MA-FAFe3O4 to those of the NIH/3T3 cells it’s a clear observation (See figures 6.2) that internal
cellular damage has occurred leading to apoptosis of the folate receptor positive cells [15]. The
increased cell death of the 5RP7 cells was most likely due to the increased uptake of the
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magnetic nano-particle conjugates resulting from the formation and endocytosis of the folic
acid/FR complex in which NIH3T3 cells are deficient resulting in the higher cell viability.
Figure 6 TEM images showing of Fe3O4 nanoparticles [15].

Figure 6.1 TEM images of NIH/3T3 cells treated with 4.5µg/ml of nano-conjugate (a) after 24
hr treatment and (b) after 48 hr treatment [15]
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Figures 6.2 TEM images of 5RP7 cells indicating apoptosis after e. 24 hr treatment of 4.5µg/ml
of nano-conjugate and f. 48 hr treatment leading to cell death [15].

Quantum Dots
Quantum dots which are semiconductor nanocrystals are a good source for use in bioimaging of cancer. Quantum dots such as CdSe, CdS, ZnS, PbS, and PSe are very beneficial in
that their absorption properties can be tuned from visible to near infrared region which allows
them to emit a multitude of colors with very intense signals depending on their size and the
wavelength of the excitation source. One of the drawbacks to quantum dots is their long lived
circulation in the blood stream which increases their toxicity level [16, 17, 18]. There has been
an effort to reduce the toxicity of quantum dots by tethering them to folic acid in conjugation
with silicon a non-toxic agent to form FA-Si-QD (See Figure 7). The formation of Si-QD
20

nanoparticles tends to have lower toxicity levels compared to conventional QDs and results in
quick expulsion through the renal system as silicic acid [18]. (See Figure 7.1). Folate receptor
positive cells that were incubated with FA-Si-QDs and then pre-saturated with folic acid show
very low luminescence in Panc-1 cells. Panc-1 cells that are incubated with FA-Si-QDs without
any pre-saturation of folic acid result in higher cellular uptake and is clearly visualized by false
color confocal images. Si-QDs are good agents for conjugation to folic acid for further research
allowing for real time visualization [18]. (See Figure 7.2) Cytotoxicity assays carried out on
human pancreatic cells using hydrogen terminated Silicone quantum dots and cysteine capped
CdTe QDs indicates that there is a higher cell viability of Panc-1 cells when exposed to Si QDs
compared to the conventional QDs such as CdTe [18].
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Figure 7 a. hydrosilylation with undecylenic acid; b. EDC coupling to the o-acylisurea ester; c.
formation of NHS-ester; d. bioconjugation [18].
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Figure 7.1
b. False color confocal images of Panc-1 cells incubated with FA-Si-QDs after saturation with
excess folic acid which is preventing the internalization nanoparticles conjugates. c. Panc-1
cancer cells incubated with FA-Si-QD alone. The bright green fluorescence clearly indicates
cellular uptake of the nanoparticles [18].
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Figure 7.2 Comparison of cytotoxicity assays of Si-QDs and CdTe quantum dots in µg/ml it
can be seen that the at high concentration range of Si-QDs cell viability is higher compared to
the cell viability cells treated with CdTe quantum dots [18].
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Gold Nanoparticles
Gold has had a place in the field of medicine ever since ancient times and has been known to
be used by the Chinese for its therapeutic purposes. Red colloidal gold is used by the elderly in
India as an ayurvedic medicine for revitalization and rejuvenation. Gold because of its non-toxic
properties has worked its way into western medicine for the treatment of certain disorders such
as epilepsy and other nervous disorders [12, 16]. Gold is the most stable of all the metals and
what makes it so attractive in nano medicine is its biocompatibility, its ease of use when
designing new nano-conjugates, and SPR (surface plasmon resonance) bands that allows for easy
characterization [11, 16]. Gold nanoparticles exhibit scattering at two wavelengths which are
tunable in the visible as well as the near IR region and is due to their SPR. Gold nanoshells
made from a silica core with a coating of gold nanoparticles showed resonance at 700-750 nm
for a 20 nm gold nanoshell with a 60 nm silica core, the same size silica core with a 5 nm gold
nanoshell resonated between 1000 and 1050 nm [16, 17]. Gold is very useful in the delivery of
nano-medicines because its stability in vitro and wide pH range (2-12) that it can take on once
endocytosed by the cell [11].
The absorbance of light in the visible region by the gold nanoparticles is what makes it so
useful in the thermal destruction of cancerous cells in a process called nanophotothermolysis. In
the process of photothermolysis AuNPs absorb light and tend to build up heat within a
picosecond time scale causing destruction of local cells that are targeted [19]. Zharov et el.
determined that a 30 nm AuNP irradiated at a wavelength of 532 nm with a fluence equal to 0.5
J/cm² and after a 20 ns pulse could produce temperatures up to 2500 K which can be used to
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destroy cancerous cells [19]. In two separate studies Mansoori conjugated (See Fiure 8) (4 atp),
4-aminothiophenol with AuNPs via thiol group to form 4atp-AuNPs which was then conjugated
to folic acid by amine binding. Using the AuNP nano-conjugate that were designed Mansoori
was able to target HeLa cancer cells that are FR+ as well as cause thermal ablation of the cells by
nanophotothermolysis and then compared data of the cellular uptake and cell death in MCF7
cells that are FR- determining that the Folate-4atp-AuNP is a very suitable agent for selective
targeting of cancer.
Figure 8. Diagram for the reaction of 4-aminothiophenol to AuNps and then folic acid [20].
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To test for the cytotoxicity of the AuNP nano-conjugate on the two different cell lines such
as FR- MCF7 cells and FR+ HeLa cells Mansoori et el incubated the cells with Folate-4atpAuNP for 1, 2 and 4 hour periods and observed that there was no cell lethality for either MCF7
or HeLa cells as can be seen from (figure 8.1) [19, 20].
Figure 8.1 Cytotoxicity assay of AuNP nano-conjugate on HeLa and MCF7 cell for 1 and 2 hour
incubation periods [20].

Folate receptor negative MCF7 cells and folate receptor positive HeLa cells were subjected to
an Intense Pulse light (IPL) to determine the cell lethality when exposed to varying pulses of
light with treatment parameters that consisted of 15 J/cm² for energy fluency, with a cut off filter
of 560 nm and a pulse duration of 3 milliseconds. Both cell lines were exposed to 10, 15, 20, 30,
and 40 pulses [19, 20]. From observation of the data in figure 8.2 it can be concluded that there
was no cell lethality and that IPL does not cause destruction of either cell lines when exposed to
27

20 pulses and the correct specifications resulting in a suitable number of pulses to use when
irradiating the cells containing the entrapped cargo. Cell viability of both HeLa , and MCF7 cells
did drop but only after exposure to pulses of 30 and 40 [19,20].
Figure 8.2 Percent survival of HeLa and MCF7 cells after exposure to varying numbers of IPL
with an operating mode: 8 mm x 15 mm; fluency 15 J/cm²; filter wavelength 560 nm; pulse
duration of 3 milliseconds [19].

Knowing that Folate-4atp-AuNP indicated no cytotoxic effects on HeLa and MCF7 cells
and with the correct number of pulses for IPL Mansoori was able to show that there is a
significant difference in cell viability between FR+ HeLa cells and FR- MCF7 cells that are
incubated with Folate-4atp-AuNp and exposed to irradiation as observed from (figure 8.3).
Each cell line was incubated with a specific concentration of the nano-conjugate then irradiated
in 3 millisecond increments to observe the effects of photothermolysis on FR+ cells as well as
FR- cells. It’s obvious that exposure to different concentrations of nano-conjugates and (IPL)
Intense pulsed light to FR- MCF7 cells shows no cell lethality where the FR+ HeLa cells do
indicate cell death. The fastest increase in cell destruction occurred when 5 µg/ml of the nano28

conjugate was added and the incubation time was changed from 1 hour incubation to 2 hour
incubation which had only 29 % cell survival where the incubation period for 1 hour showed 77
% cell survival [19, 20]. Using the AuNP nano-conjugate tethered to 4-aminthiophenol and
folate Mansoori was able to show the cellular uptake of the nano-conjugate by FR+ HeLa cells,
that no toxicity occurred when the cells where incubated with the nano-conjugate alone as well
as the destruction of FR+ HeLa cells.
Figure 8.3 Percent survival of Hela and MCF7 cells after 1, 2, and 4 hour exposure to nanoconjugate and radiated with IPL [20]
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Liposomes
Liposomes which are mainly composed of phospholipid bilayers are very useful in the
delivery of a medicines, enzymes, coenzymes, genetic material and are able to entrap a high
concentration of payloads to the site of infection either by passive, or active targeting [21]. As
the nature and function of liposomes was further understood researchers were able to attach other
functional molecules such as PEG to their surface in order to increase longer circulation in vivo
by preventing the non-specific opsonisation by phagocytes. Liposomes have the capability of
encasing hydrophilic and hydrophobic molecules and at the same time maintain all cellular
activities such as accumulation at the target tissue due to long systematic circulation and
controlled drug release [22, 23]. Liposomes are able to infiltrate the tumor cells mainly by
passive targeting by way of the enhanced permeability and retention effect through the leaky
vasculature associated with the tumor. Liposome infiltration into the tumor cells can be
increased by conjugation to folic acid resulting in an increased efficiency and delivery of the
payload within the liposome. With the advancements and technology in the treatment of cancer
liposomes have been tethered to Gadolonium which allows for MRI imaging of tumor cells.
Liposomes have also been used for entrapping and delivery of ZnTPP (zinctetraphyenylporphryn) a photosensitizers in an effort to minimize the unwanted side effects due
to normal tissue damage as well as to destroy the tumor cells with photodynamic therapy.
In a 2009 study which researched the uptake and MRI imaging of cancer cells used (See
Figure 9) targeted liposomes consisting of Gd.DOTA.DSA/DOPC/Cholesterol/DSPEPEG2000/DSPE-PEG(2000)Folate/DOPE-Rhodaamine 30/32/30/4/3/10 mol % , and nontargeted liposome formulation which consisted of Gd.DOTA.DSA/DOPC/Cholesterol/DSPEPEG2000/DOPE-Rhodamine with a molar ratio of 30/32/30/7/1 mol % (50). IGROV-1 cancer
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cells having an overexpression of folate receptor on the cell surface were incubated with targeted
and non-targeted liposomes and then compared post incubation. To test for the internalization of
157Gd by IGROV-1 cells ICP-AES measurements were conducted. (See Figure 9.1) ICP-AES
analysis of IGROV-1 cells incubated for 5 hours with non-targeted liposomes and 0.03 mol %
folate liposomes shows very low concentrations in ppm of Gadolonium-157 being internalized
by the cells. Observing IGROV-1 cells that were incubated with targeted liposomes containing 3
mol % of folate shows a very high concentration of 157Gd internalized by the cells indicating
that folate conjugated liposomes are more preferably taken up by the FR+ IGROV-1 cells (50).
Targeted and non-targeted liposomes were injected into tumor bearing mice for MRI
imaging. MRI scans of the tumor bearing mice were conducted in order to identify the tumor
and determine the T1 baseline value using a 4.7 T magnet. Post injection the mice were then
imaged at 2, 16, and 24 hrs and the weighted T1 images for each respective time point was
determined. From Observation of (figure 9.2) it is clear that there is an increase in The MRI
signal after 2 hour post injection and that specific targeting of the tumor cells by folate liposomes
has occurred. MRI imaging of tumors that have been exposed to folate targeted and non-targeted
liposomes can be seen in (figure 9.3) where it is also observed that there is an increase in signal
intensity after 2 hour post injection of folate targeted liposomes [24]. After MRI imagining was
completed liver and kidney sections from tumor bearing mice were analyzed by fluorescence
microscopy imaging to determine if the folate targeted and non-targeted liposomes have
infiltrated healthy liver and kidney tissues. From the microscopy images of the liver and kidneys
there is low fluorescence intensity indicating that the liposomes have not infiltrated the healthy
cells in these specific organs and that long systematic circulation is occurring due to the
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pegylation of the liposomes resulting in accumulation within FR+ IGROV-1 cells of the tumor
bearing mice [24].

Figure 9 Schematic picture of Folate-targeted liposome [24].

Figure 9.1 ICP-AES analysis of the cellular uptake of 157Gd after 5 hour incubation period [24].
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Figure 9.2 Mouse tumor enhancement using folate targeted and non-targeted liposomes. (a) T1
measurement at 4.7 T. (b) signal enhancement determined from the mean tumor T1 values for
pre- and post-liposomal injection [24].
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Figure 9.3 MRI images of tumor earing Balb/C nude mice: top images indicate mice injected
with folate targeted liposomes at 2, 16, and 24 hours; bottom images are of tumor bearing mice
injected with nontargeted liposomes at 2, 16, and 24 hours [24].

Liposome encapsulated ZnTPP
Photodynamic therapy is a light based therapy and has been used in the treatment of many
conditions including certain cancers. Photodynamic therapy depends on the photosensitization of
a photosensitizer which can be locally applied or injected into a specific area. The
photosensitizer once exposed to a certain wavelength of light initiates the production of ¹O2
(singlet oxygen) from normal oxygen within the tissue. Singlet oxygen is the main ROS reactive
oxygen species thought to be the cause of cell death as a result of photo induction [22]. The
main objective with photodynamic therapy is to cause cytotoxic cell death by the activation of
¹O2 and at the same time minimize destruction of healthy normal tissue that leads to unwanted
side effects.
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Garcia Diaz et el. were able to design a nano-conjugates consisting of ZnTPP entrapped in
liposomes in a molar ratio of 100:1 lipid/porphyrin and then tethered to folic acid in order to
compare the cellular uptake and photocytotoxicity by FR+ HeLa cells and FR- A549 cells.
Liposomes were prepared by microemulsification process and consisted of non-targeted
liposomes POPC/OOPS with a molar ratio of 90:10 and folate targeted liposomes
POPC/OOPS/FA-PEG-DSPE with a molar ratio of 90:10:0.01. With 85% cell survival for both
folate targeted and non-targeted liposomes a concentration of 10µM ZnTPP was used as an
adequate concentration for the delivery to both cell lines [22]. In this study Garcia et el. was able
to determine that encapsulation efficacy of the photosensitizer was close to 90% and that the PS
was not affected by the incorporation of the folic acid (See table 10). They also tested for
liposome stability to assure that none of the entrapped poryphrin is released from liposomes
interacting with other proteins or with one another.
Table 1. Stability of folate targeted and non-targeted liposome measured by lipid and
photosensitizer content [22].
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Folate receptor positive HeLa cells and Folate negative A549 cells were incubated for 24
hours with folate targeted and non-targeted liposomes containing ZnTPP photosensitizer then
lysed and analyzed by fluorescence spectroscopy to determine the uptake of liposomes and PS by
the cells. By clear observation of (Figure 10) there is a difference in the uptake of PS by HeLa
cells and A549 cells. Comparing the fluorescence intensity of the cell lysates for both HeLa, and
A549 cells incubated with both non-targeted, and folate targeted liposomes it is clear that the
HeLa cells which are folate receptor positive have a much stronger fluorescence intensity then
the folate receptor negative cells indicating that the cellular uptake of the liposomes with
entrapped ZnTPP has occurred [22].
To test for photodynamic toxicity, the uptake of folate targeted liposomes, and non-targeted
liposomes photosensitization experiments were carried out on HeLa, cells (See figure 10.1) that
were incubated for a 24 hour period in both liposomes formulations. HeLa cells were exposed
to three different concentrations of ZnTPP encased in liposomes then irradiated with green LED
light. As observed from (Figure 10.1A) there is a decrease in the number of viable HeLa cells
that have been exposed to different concentrations of the poryphrin as well as light but HeLa
cells that were incubated with folate targeted liposomes (Figure 10.1B) indicate that there is a
higher increase in toxicity indicating that cell cytotoxicity is dependent on concentration as well
as photodynamic response [22]. Garcia et el. also used photodynamic toxicity to compare the
folate targeting efficiency of both cell lines with a concentration of 1µM ZnTPP throughout and
irradiated with 10 Jcm². Analysis of both HeLa and A549 cells (See figure 10.2) indicates that
the HeLa cells which are folate receptor positive cells show a higher percent in cell death then
A549 cells which remained at the same percent whether incubated with folate-targeted or non-
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targeted liposomes. This data clearly indicates that there is a significant difference in the uptake
and increase in toxicity of the nano-conjugates and is dependent on folate receptor binding [22].

Figure 10. Cellular uptake of ZnTPP encapsulated in Folate targeted liposomes ( ) and
nontargeted liposome ( ) by (A) HeLa cells and (B) A549 cells in folate depleted DMEM [22].

Figure 10.1 Concentration and irradiation time dependence of phototoxicity of ZnTPP
encapsulated in (A) non-targeted liposomes and (B) Folate- targeted liposomes By HeLa cells.
Concentrations are ( ) 0.1µM, ( ) 1µM, and ( ) 10 µM [22].
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Figure 10.2 Photodynamic cytotoxicity using 1µM ZnTPP encapsulated in liposomes with light
intensity set to 10 Jcm² (A) non-targeted liposomes and (B) Folate-targeted liposomes. p < 0.001
[22].
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Conclusion
Discovery of the folate receptor on the membrane surface of many cancers and the use of
folic acid conjugated to nanoparticles as a moiety for the delivery of therapeutic and imaging
agents has been a great achievement in the fight against cancer, and other diseases. The cellular
uptake, toxicity affects, and bio-imaging capabilities for real time tracking of the nanoconjugates as well as site specific imaging of the cancer such as MRI for a variety of
nanoparticles conjugated to folic acid has been reviewed. Folic acid conjugated nanoparticles
show promising results in the fight against cancer in that there is a better understanding in the
functionalities of the nanoparticles. In designing and formulating folate nanoparticles to increase
the efficiency in targeting cancer cells pH environments within the cells were considered. The
Attachment of ligands on the surface of multifunctional nanoparticles was also implemented and
researched to provide better systematic circulation and delivery of a large payload via the nanoconjugate. As time progresses researchers are developing newer and more advanced methods for
manipulating folate nanoparticle nano-conjugates leading to a more efficient targeting system for
bio-imaging and destruction of the cancer without causing cell death to surrounding healthy
tissue.
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